Clinical trial
Fimasartan/Amlodipine Combination Phase III
NCT02152306
Study timeline
Study start (unknown)2014-04-01Date precision: month
Registry last updated2015-07-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
Sponsors & collaborators
Boryung Pharmaceutical Co., Ltdlead sponsor
Gachon University Gil Medical Centercollaborator
The Catholic University of Koreacollaborator
Kangbuk Samsung Hospitalcollaborator
Kyungpook National University Hospitalcollaborator
Keimyung University Dongsan Medical Centercollaborator
Korea University Guro Hospitalcollaborator
Korea University Anam Hospitalcollaborator
DongGuk Universitycollaborator
Dong-A University Hospitalcollaborator
Pusan National University Hospitalcollaborator
Seoul National University Bundang Hospitalcollaborator
Seoul National University Hospitalcollaborator
Asan Medical Centercollaborator
Pusan National University Yangsan Hospitalcollaborator
Wonju Severance Christian Hospitalcollaborator
Gangnam Severance Hospitalcollaborator
Severance Hospitalcollaborator
Ulsan University Hospitalcollaborator
Inje Universitycollaborator
Inje University Haeundae Paik Hospitalcollaborator
Chonnam National University Hospitalcollaborator
Jeju National University Hospitalcollaborator
Chungnam National Universitycollaborator
Hanyang University Seoul Hospitalcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02152306 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.